Oncology & Hematology Coding Alert

You Be the Coder:

Take This Multiple Myeloma Challenge

Question: The following administration encounter is for a patient with high risk monoclonal IgG kappa multiple myeloma, relapse confirmed with bone marrow biopsy. Which codes apply to this case? 8A-10A, IV Aredia, 30 mg 10:05A-10:06A, push IV Aloxi, 0.25 mg 10:10A-10:25A, push IV dexamethasone, 20 mg 10:45A-11:40A, IV Cytoxan, 500 mg

Colorado Subscriber Answer: The appropriate diagnosis [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All